Logos Global Management as of June 30, 2020
Portfolio Holdings for Logos Global Management
Logos Global Management holds 46 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Forma Therapeutics Hldgs SHS | 11.9 | $60M | 1.3M | 46.49 | |
| Reata Pharmaceuticals Cl A | 6.2 | $31M | 200k | 156.02 | |
| Celldex Therapeutics Com New (CLDX) | 5.2 | $26M | 2.0M | 13.00 | |
| Avidity Biosciences Ord (RNA) | 5.1 | $26M | 927k | 27.58 | |
| Repare Therapeutics Ord | 4.1 | $20M | 667k | 30.43 | |
| Biontech Se Sponsored Ads (BNTX) | 3.9 | $20M | 295k | 66.74 | |
| Cytokinetics Com New (CYTK) | 3.8 | $19M | 800k | 23.57 | |
| Arena Pharmaceuticals Com New | 3.4 | $17M | 269k | 62.95 | |
| Applied Molecular Trans | 3.3 | $17M | 664k | 25.14 | |
| Tg Therapeutics (TGTX) | 3.3 | $17M | 850k | 19.48 | |
| Akebia Therapeutics (AKBA) | 3.3 | $16M | 1.2M | 13.58 | |
| Bioxcel Therapeutics | 3.2 | $16M | 300k | 53.01 | |
| Immunovant (IMVT) | 3.0 | $15M | 625k | 24.35 | |
| Keros Therapeutics (KROS) | 3.0 | $15M | 400k | 37.51 | |
| Pliant Therapeutics (PLRX) | 2.9 | $15M | 456k | 31.92 | |
| Vaxcyte (PCVX) | 2.9 | $14M | 455k | 31.61 | |
| Bristol-myers Squibb Right 99/99/9999 | 2.9 | $14M | 4.0M | 3.58 | |
| Zogenix Com New | 2.2 | $11M | 400k | 27.01 | |
| Akouos | 2.0 | $10M | 450k | 22.50 | |
| Principia Biopharma | 1.8 | $9.0M | 150k | 59.79 | |
| Global Blood Therapeutics In | 1.7 | $8.5M | 135k | 63.13 | |
| Passage Bio | 1.7 | $8.5M | 344k | 24.60 | |
| Fulcrum Therapeutics (FULC) | 1.5 | $7.5M | 410k | 18.29 | |
| Calliditas Therapeutics Ab Sponsered Ads | 1.4 | $7.0M | 300k | 23.30 | |
| Obseva Sa | 1.4 | $6.9M | 1.2M | 5.89 | |
| Generation Bio | 1.4 | $6.8M | 325k | 21.00 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $6.8M | 563k | 12.10 | |
| Igm Biosciences (IGMS) | 1.3 | $6.7M | 92k | 73.00 | |
| Bellus Health Com New | 1.2 | $6.2M | 600k | 10.29 | |
| 89bio (ETNB) | 1.2 | $5.8M | 290k | 19.93 | |
| Aptose Biosciences Com New | 0.9 | $4.7M | 750k | 6.31 | |
| Black Diamond Therapeutics (BDTX) | 0.9 | $4.7M | 124k | 37.95 | |
| Springworks Therapeutics (SWTX) | 0.9 | $4.6M | 110k | 42.00 | |
| Iveric Bio | 0.9 | $4.6M | 900k | 5.10 | |
| Rapt Therapeutics | 0.9 | $4.5M | 155k | 29.02 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.9 | $4.4M | 400k | 11.00 | |
| Rocket Pharmaceuticals (RCKT) | 0.6 | $3.1M | 150k | 20.93 | |
| Sutro Biopharma | 0.6 | $2.8M | 362k | 7.76 | |
| Fusion Pharmaceuticals | 0.4 | $2.1M | 121k | 17.47 | |
| Chardan Healthcr Acqstn 2 Unit 99/99/9999 | 0.4 | $2.1M | 200k | 10.50 | |
| X4 Pharmaceuticals | 0.3 | $1.5M | 159k | 9.32 | |
| Arya Sciences Acquistion Unit 06/09/2027 | 0.2 | $1.2M | 100k | 11.60 | |
| Lumos Pharma | 0.2 | $825k | 50k | 16.50 | |
| Larimar Therapeutics (LRMR) | 0.1 | $739k | 58k | 12.86 | |
| Mereo Biopharma Group Ads (MREO) | 0.1 | $612k | 200k | 3.06 | |
| Applied Therapeutics | 0.1 | $455k | 13k | 36.11 |
